Policies on Conflict of Interest, Human and Animal rights, and Informed Consent
A competing interest exists when the author(s) interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
The Journal of Chitwan Medical College requires authors to disclose all competing interests in relation to their work. All submitted manuscripts must include a ‘Conflict of Interest’ section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no conflict of interests, the statement should read “None.” Editors may ask for further information relating to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.
Competing interests may be financial or non-financial.
Financial competing interests include (but are not limited to):
– Receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
– Holding stocks or shares in an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
– Holding, or currently applying for, patents relating to the content of the manuscript.
– Receiving reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript.
Non-financial competing interests
– Non-financial competing interests include (but are not limited to) political, personal, religious, ideological, academic, and intellectual competing interests. If, after reading these guidelines, you are unsure whether you have a competing interest, please contact the Editor.
Authors associated with commercial organizations and pharmaceutical companies sponsoring the clinical trials should disclose the competing interests during submission. The authors should adhere to the Good Publication Practice guidelines for the organizations and companies they are attached with. This also applies to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations and communications companies.
Human and Animal Rights
All research must have been carried out ethically. If there is suspicion that work has not been done ethically, the chances of rejection of manuscript is high, and/or contact the author(s)’ ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Human rights
Studies involving human participants must be performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. The submitted study has to be supported by the ethics/bioethics committee approval and the name of the ethics committee and the reference number where appropriate, must appear in the methods section of the manuscript. Even for study exempted from requiring ethical approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to Editors on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information.
Authors reporting the use of a new procedure or tool in a clinical setting, for example as a technical advance or case report, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient’s clinical need. Such justification is not required if the new procedure is already approved for clinical use at the authors’ institution. Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.
Animal rights
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript while performing animal research.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee.
If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption).
The Editor will take into the account the animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. The three R(s) -Replacement, Refinement and Reduction of Animals in Research (NC3Rs) has to be maintained. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals.
For studies reporting livestock trials with production, health and food-safety outcomes, authors are encouraged to adhere to the Reporting Guidelines for Randomized Controlled Trials in Livestock and Food Safety (REFLECT).
US authors should cite compliance with the US National Research Council’s Guide for the Care and Use of Laboratory Animals, the US Public Health Service’s Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
European authors outside the UK should conform to Directive 2010/63/EU.
Nepalese authors performing animal experiments should also adhere to the animal guidelines published by Nepal Health Research Council.
The authors should comply with the Convention on the Trade in Endangered Species of Wild Fauna and Flora and the IUCN Policy Statement on Research Involving Species at Risk of Extinction.
The chief editor, members of the editorial board and scientific committee, and reviewers shall withdraw in any case of conflict of interest concerning an author or authors, or the content of a manuscript to be evaluated. The Journal will avoid all conflict of interest between authors, reviewers, and members of the editorial board and international scientific committee.
Informed Consent
Informed Consent- Study Participants-
Authors should not include identifying patient information, including patients' names, initials, or hospital numbers, in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent/ guardian) gives written, informed consent for publication.
Complete anonymity is difficult to achieve; however, informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 18) and it should be indicated in the published article and a copy of the 'Patient Informed Consent Form' may be asked to the author in case of suspicion and it should be provided to the journal.
If the participant has died, then consent for publication must be sought from the next of kin of the participant. This documentation must be made available to Editors on request, and will be treated confidentially.
Authors should provide written verification that any study participants who are identifiable have been shown the final manuscript to be published. The final decision on whether consent to publish is required lies with the Editor.
Masked Study Participants- If identifying characteristics are altered to protect anonymity, such as in genetic malformations, authors should provide written assurance to the editors that alterations do not distort scientific meaning.
For experimental studies involving client-owned animals, authors must also document informed consent from the client or owner and adherence to a high standard (best practice) of veterinary care.